News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
AstraZeneca's long-acting antibody combination Evusheld has been approved in Japan for both prevention (pre-exposure prophylaxis) and treatment of symptomatic disease caused by SARS-CoV-2 infection: marking the first global marketing approval of Evusheld...
Applied StemCell is expanding its cGMP facility to increase its cell banking and cell product manufacturing capacity.
Thermo Fisher Scientific has opened its new viral vector manufacturing facility in Plainville, Massachusetts.
Organization extends turnkey research facility network to San Diego, San Francisco, Thousand Oaks, and Seattle.